Welcome to JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES) June 11, 2025
DENG Jian-jun, ZHU Jia-ni, YANG Chen-lu, et al. Clinical Distribution and Drug Resistance of Staphylococcus Aureus Isolated from Hospitalized Children[J]. Journal of Sichuan University (Medical Sciences), 2013, 44(1): 159-161.
Citation: DENG Jian-jun, ZHU Jia-ni, YANG Chen-lu, et al. Clinical Distribution and Drug Resistance of Staphylococcus Aureus Isolated from Hospitalized Children[J]. Journal of Sichuan University (Medical Sciences), 2013, 44(1): 159-161.

Clinical Distribution and Drug Resistance of Staphylococcus Aureus Isolated from Hospitalized Children

More Information
  • Received Date: July 02, 2012
  • Revised Date: October 25, 2012
  • Published Date: January 19, 2013
  • Objective To learn about the clinical distribution and drug resistance of Staphylococcus aureus (S.aureus) isolated from inpatients and provide evidence for clinically reasonable use of antibiotics. Methods Data including clinical features and drug sensitivity of S.aureus isolated from hospitalized patients in the last two years were analyzed. Results 248 S.aureus strains were isolated from inpatients of our hospital in the last 2 years. The most common disease caused by S.aureus was pneumonia with a total of 163 patients. The second was skin and soft tissue infection with 21 patients in total. Sepsis occurred in 11 patients.The most commonly used antibiotics included oxacillin, nafcillin, cefathiamidine and vancomycin. The average course of antibiotic was 12.48 days. Treatment course of pneumonia and sepsis was 13.71 and 15.11 respectively. 96.31% (235/244) of S.aureus were resistant to penicillin. Vancomycin-resistant S.aureus has not been isolated. Conclusion S.aureus pneumonia is the leading cause of hospitalization of children with S.aureus infection. S.aureus is highly resistant to commonly used antibiotics and related infections need longer therapy. Clinicians should pay more attention to S.aureus infection.
  • [1]
    Lamaro-Cardoso J, de Lencastre H, Kipnis A, et al. Molecular epidemiology and risk factors for nasal carriage of Staphylococcus aureus and methicillin-resistant S.aureus in infants attending day care centers in Brazil. J Clin Microbiol,2009;47(12):3991-3997.
    [2]
    Alfadhel M, Puapermpoonsiri U, Ford SJ, et al. Lyophilized inserts for nasal administration harboring bacteriophage selective for Staphylococcus aureus: in vitro evaluation. Int J Pharm,2011;416(1):280-287.
    [3]
    Ena J, Boelaert JR, Boyken LD,et al. Epidemiology of Staphylococcus aureus infections in patients on hemodialysis. Infect Control Hosp Epidemiol,1994;15(2):78-81.
    [4]
    Budimir A, Deurenberg RH, Plecko V, et al. Molecular characterization of methicillin-resistant Staphylococcus aureus bloodstream isolates from Croatia. J Antimicrob Chemother,2006;57(2):331-334.
    [5]
    胡英惠, 甄景慧, 赵德环.小儿社区获得性耐甲氧西林金黄色葡萄球菌感染临床分析.中国当代儿科杂志,2006;8(4):298-300.
    [6]
    汪 玲, 陆 权, 王传清等.2000~2004年京沪穗渝5家儿童医院革兰氏阳性球菌耐药情况分析.中国循征儿科杂志,2006;1(2):113-120.
    [7]
    王清涛, 杜小玲, 曲寿山等.金黄色葡萄球菌耐药性分析.中华医学检验杂志,1996;19(2):186-188.
    [8]
    Bartley J. First case of VRSA identified in Michigan. Infect Control Hosp Epidemiol,2002;23(8):480.
    [9] 毕少杰, 于 晶, 刘 婷等.济南地区异质性万古霉素中介金葡菌的分离率及方法研究. 山东大学学报(医学版),2010;48(6):41-44.

Catalog

    Article views (2785) PDF downloads (54) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return